 intrathec immun respons patient post-polio syndrom background syndrom progress muscular atrophi decad acut paralyt poliomyel post-polio syndrom theori physiolog chang new weak immunolog abnorm patient altern explan persist recurr polioviru infect method intrathec antibodi respons intrathec product solubl receptor patient post-polio syndrom control poliomyel new symptom amyotroph later sclerosi intrathec antibodi respons measl mump herp varicella zoster virus result oligoclon igm specif cerebrospin fluid patient post-polio syndrom percent none control group quantit studi evid increas intrathec synthesi igm antibodi patient post-polio syndrom increas synthesi igm measl mump herp varicella zoster virus patient post-polio syndrom mean SD cerebrospin fluid level solubl receptor control millilit millilit intrathec synthesi igm antibodi cerebrospin fluid concentr solubl receptor conclus intrathec immun respons polioviru present mani patient post-polio syndrom patient recrudesc muscl weak persist recurr infect neural cell polioviru